How to improve current therapeutic standards in upper respiratory infections: Value of fusafungine

Current Medical Research and Opinion

Volumn 20, Issue 11, 2004, Pages 1769-1776

  German Fattal, Michèle ^a   Mösges, Ralph ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Fusafungine; Local antibiotic treatment; Upper respiratory tract infection

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BUDESONIDE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; DECONGESTIVE AGENT; FLUTICASONE PROPIONATE; FUSAFUNGINE; MUCOLYTIC AGENT; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VASOCONSTRICTOR AGENT;

ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL INFECTION; CHILD; COST OF ILLNESS; DRUG MECHANISM; DRUG TARGETING; DRUG UTILIZATION; DRY NOSE; EPISTAXIS; HUMAN; INFLAMMATION; NONHUMAN; NOSE INFECTION; NOSE OBSTRUCTION; PALLIATIVE THERAPY; PHARYNGITIS; PRACTICE GUIDELINE; PRESCRIPTION; RESPIRATORY TRACT MUCOSA; RHINORRHEA; SIDE EFFECT; SORE THROAT; SYSTEMIC THERAPY; TISSUE INJURY; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

ADMINISTRATION, TOPICAL; AEROSOLS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FUSARIUM; HUMANS; RESPIRATORY TRACT INFECTIONS;

EID: 10044248275     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904X5535     Document Type: Article

References (54)

1. Hendley JO. Epidemiology, pathogenesis, and treatment of the common cold. Semin Pediatr Infect Dis 1998;9:50-5
2. Kaiser L, Lew D, Hirschel B, et al. Effect of antibiotic treatment in the subset of common cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996;347:1507-10
3. Gonzales R, Malone DC, Maselli JH, et al. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001;15:757-62
4. Agence du Médicament (AFSSaPS). Antibiothérapie par voie générale en pratique courante: infections ORL et respiratoires basses. Presse Med 1999 28:406-14
5. Centre de Coordination de la Lutte contre les Infections Nosocomiales de l'Interrégion Paris-Nord (CCLIN Paris-Nord). Surveillance des bactéries multirésistantes à partir du laboratoire dans les hôpitaux de l'interrégion Paris-Nord (hors Assistance Publique-Hôpitaux de Paris): rapport des résultats 2001. Paris: CCLlN Paris Nord; 2002
6. Witte W. Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 1999;44:1-9
7. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001;357:1851-3
8. Klugman KP, Goldstein F, Kohno S, et al. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin Microbiol Infect 1997;3(Suppl.1):S48-S60
9. Laurans G, Murbach V, Cattier B, et al. Observatoires régionaux du pneumocoque: surveillance de la sensibilité aux antibiotiques des pneumocoques isolés en situation pathogène en France en 1999. B.E.H. No 33, 2001
10. Pichichero ME. Resistant respiratory pathogens and extended-spectrum antibiotics. Am Fam Physician 1995;52:1739-46
11. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001;357:1851-3
12. Guillemot D. Les antibiotiques sont-ils surconsommés? Rev Prat 1998;48:585-6
13. Ball P, Baquero F, Cars O, et al.; The Consensus Group on Resistance and Prescribing in Respiratory Tract Infection. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002;49:31-40
14. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001;134:479-86
15. Agence Francaise de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Antibiothérapie par voie générale en pratique courante: infections ORL et respiratoires basses. Ann Otolaryngol Chir Cervicofac 1999;116:302-14
16. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Antibiothérapie par voie géné rale en pratique courante: infections ORL et respiratoires basses. Rhinopharyngite aiguë. Synthèse, recommandation, argumentaire. Ann Otolaryngol Chir Cervicofac 1999;116:302-14
17. AFSSaPS. Antibiothérapie par voie générale en pratique courante: angine. Recommandation. Réactualisation 2002
18. Références médicales opposables. Prescription des antibiotiques en pratique courante. Infections ORL et respiratoires. Journal Officiel 14 novembre 1998
19. Bradley CP. Decision making and prescribing patterns - a literature review. Fam Pract 1991;8:276-87
20. Greenhalgh T, Gill P. Pressure to prescribe. Br Med J 1997;315:1482-3
21. Cockburn J, Pit S. Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations - a questionnaire study Br Med J 1997;315:520-3
22. Misrahi L, Bourrillon A, Lebrun T, Dervaux B. Antibiotics for nasopharyngitis in children, in France: the gap between guidelines and daily practice. Med Mal Infect 2003;33:570-8
23. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35:113-25
24. Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Dande MA. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Emerg Med 2001;37:698-702
25. Hickner JM, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001;134:498-505
26. Cooper RJ, Hoffmann JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001;134:509-17
27. Laccoureye O, Cauchois R, Landais P, German-Fattal M. The impact of fusafungine on the prescription of antibiotics in the treatment of rhinopharyngitis in France. Press Med 2003;32:615-9
28. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Antibiothérapie par voie géné rale en pratique courante: infections ORL et respiratoires basses. Rhinopharyngite aiguë. Agence du Médicament; 1999
29. Wilson R, Alton E, Rutman A, et al. Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis 1987;70:272-9
30. Hendley JO. Epidemiology, pathogenesis, and treatment of the common cold. Sem Pediatr Infect Dis 1998;9:50-5
31. 1-receptors in the nasal mucosa: a mystery solved? Clin Exp Allergy 1996;26:368-70
32. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993;307:982-6
33. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br Med J 1995;310:1125-9
34. François M. Place des traitements non antibiotiques (généraux et locaux) dans la rhinopharyngite. Med Mal Infect 1997;27sp:367-71
35. Boek WM, Graamans K, Natzijl H, van Rijk PP, Huizing EH. Nasal mucociliary transport: new evidence for a key role of ciliary beat frequency. Laryngoscope 2002;112:570-3
36. Sperber SJ, Sorrentino JV, Riker DK, Hayden FG. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bull New York Acad Med 1989;65:145-60
37. Milgrom H, Bender B. Adverse effects of medications for rhinitis. Ann Allergy Asthma Immunol 1997;78:439-46
38. Gwaltney JM Jr, Druce HM. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin Infect Dis 1997;25:1188-94
39. Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT. Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;125:89-97
40. Farr BM, Gwaltney JM Jr, Hendley JO, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990;162:1173-7
41. Gustafson LM, Proud D, Hendley JO, Hayden FG, Gwaltney JM Jr. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996;97:1009-14
42. Puhakka T, Mäkela MJ, Malmström K, et al. The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol 1998;101:726-31
43. Ruohola A, Heikkinen T, Waris M, Puhakka T, Ruuskanen O. Intranasal fluticasone propionate does not prevent acute otitis media during viral upper respiratory infection in children. J Allergy Clin Immunol 2000;106:467-71
44. Knutsson U, Stierma P, Marcus C, et al. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol 1995;144:301-10
45. Grahnen A, Eckernas SA, Brundin RM, Ling-Andersson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 1995;38:521-5
46. German-Fattal M. Fusafungine: an antimicrobial agent for the local treatment of respiratory tract infections. Clin Drug Invest 1996;12:308-17
47. German-Fattal M. Fusafungine, an antimicrobial with anti-inflammatory properties in respiratory tract infections. Clin Drug Invest 2001;21:653-70
48. Karam-Sarkis D, German-Fattal M, Bourlioux P. Effects of fusafungine on adherence of Haemophilus influenzae type b to human epithelial cells in vitro. Biomed Pharmacother 1991;45:301-6
49. Cuénant O. Value of Locabiotal® aerosol in rhinosinusitis. Rhinology 1988;(Suppl 5):69-74
50. Reinert P. Value of rapid tests for the detection of streptococcal infections: illustration by a study of Locabiotal Aerosol in tonsillitis. Maladies Med/Drugs Dis 1989;5:113-23
51. Samolinski B, Zawista E, Ardmowitz M, et al. Influence of fusafungine upon viral and bacterial infections. Med Sci Monit 1997:3:736-43
52. Kroslak M. Efficacy and acceptability of fusafungine, a local treatment for both nose and throat infections, in adult patients with upper respiratory tract infections. Curr Med Res Opin 2002;18:194-200
53. Lund V, Grouin JM, Eccles R, et al. Efficacy of fusafungine in acute rhinopharyngitis: a pooled analysis. Rhinology 2004; in press
54. Fagnani F, German-Fattal M. Antibiotic prescribing patterns of French GPs for upper respiratory tract infections. Am J Respir Med 2003;2:491-8